Criterion for Assessing Accumulated Neurotoxicity of Alpha-Synuclein Oligomers in Parkinson's Disease

3Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The paper introduces a parameter called “accumulated neurotoxicity” of α-syn oligomers, which measures the cumulative damage these toxic species inflict on neurons over time, given the years it typically takes for such damage to manifest. A threshold value for accumulated neurotoxicity is estimated, beyond which neuron death is likely. Numerical results suggest that rapid deposition of α-syn oligomers into fibrils minimizes neurotoxicity, indicating that the formation of Lewy bodies might play a neuroprotective role. Strategies such as reducing α-syn monomer production or enhancing degradation can decrease accumulated neurotoxicity. In contrast, slower degradation (reflected by longer half-lives of monomers and free aggregates) increases neurotoxicity, supporting the idea that impaired protein degradation may contribute to Parkinson's disease progression. Accumulated neurotoxicity is highly sensitive to the half-deposition time of free α-syn aggregates into fibrils, exhibiting a sharp increase as it transitions from negligible to elevated levels, indicative of neural damage.

Cite

CITATION STYLE

APA

Kuznetsov, A. V. (2025). Criterion for Assessing Accumulated Neurotoxicity of Alpha-Synuclein Oligomers in Parkinson’s Disease. International Journal for Numerical Methods in Biomedical Engineering, 41(4). https://doi.org/10.1002/cnm.70027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free